Joe DePinto: Why advanced therapies need a new delivery model

Joe DePinto: Why advanced therapies need a new delivery model

From Ori Spotlight by Ori Biotech

January 13, 2026 · 1h 5m

About this episode

Joe DePinto discusses the need for new delivery models for advanced therapies and shares insights from his experience in speciality drug distribution.

In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Joe DePinto, Head of Cell and Gene Advanced Therapies at McKesson, to explore how advanced therapies can be delivered through the same systems that support other complex medicines. Joe shares what he has learned from decades of speciality drug distribution and how those lessons are now being applied to cell and gene therapies at McKesson. From managing cold chain logistics to preparing community sites for treatment delivery, he reflects on what it takes to build practical, scalable systems that meet real-world needs. Together, he and Jason discuss the shift away from bespoke solutions and the value of adapting proven infrastructure to help CGTs reach more patients, more efficiently. Watch on YouTube: https://youtu.be/uUqX3aFKBrs Further Information ⁠Connect with Joe⁠

People in this episode

Host: Jason C. Foster

Guest: Joe DePinto

Topics covered

  • advanced therapies
  • delivery model
  • cell and gene therapies
  • speciality drug distribution
  • cold chain logistics
  • treatment delivery

Keywords

  • advanced therapies
  • delivery model
  • cell and gene therapies
  • cold chain logistics
  • treatment delivery
  • speciality drug distribution
  • scalable systems

Mentioned in this episode

Organizations: McKesson

More episodes of Ori Spotlight

Explore listener stats, chart rankings, contacts and more on the Ori Spotlight podcast page.